3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	choline-alfoscerate Compound (Entity type)	0.2868488430976867
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	GJA1 Gene (Entity type)	0.0055110003
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CXCL1 Gene (Entity type)	0.006259538
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CNN3 Gene (Entity type)	0.004768854
narlaprevir Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	0.2818394899368286
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	RGS4 Gene (Entity type)	0.0041705016
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SRC Gene (Entity type)	0.0041243406
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	LTF Gene (Entity type)	0.005622819
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Orphenadrine Compound (Entity type)	0.2995979785919189
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CXCL2 Gene (Entity type)	0.010652901

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
choline-alfoscerate
Compound (Entity type)
0.2868488430976867

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
GJA1
Gene (Entity type)
0.0055110003

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CXCL1
Gene (Entity type)
0.006259538

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CNN3
Gene (Entity type)
0.004768854

narlaprevir
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
0.2818394899368286

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
RGS4
Gene (Entity type)
0.0041705016

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SRC
Gene (Entity type)
0.0041243406

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
LTF
Gene (Entity type)
0.005622819

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Orphenadrine
Compound (Entity type)
0.2995979785919189

3-isopropyl-5-(4-((6-(4-(methylsulfonyl)phenyl)pyridin-3-yloxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CXCL2
Gene (Entity type)
0.010652901

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.